• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对一组南亚患者的脂蛋白(a)与冠状动脉疾病、脑血管疾病及外周血管疾病严重程度的横断面研究。

Cross-sectional study of lipoprotein(a) and the severity of coronary artery disease, cerebrovascular disease, and peripheral vascular disease in a group of South Asian patients.

作者信息

Athauda-Arachchi Pandula M, Kaththiriarachchi Lalindra, Salgado Wickrama, De Silva Sulakkana, Salgado Tiyara, Farooq Mumtaz, Jibran M Javid, Godakanda Arachchi Yumandi, Premanath Samidi, Senaratne Sithira L, Samarakoon Sanjalee P, Rathnayake Hiran, Shajahan Miriam

机构信息

General Sir John Defence University.

Durdans Hospital Colombo, Colombo, Sri Lanka.

出版信息

Cardiovasc Endocrinol Metab. 2025 Mar 27;14(2):e00327. doi: 10.1097/XCE.0000000000000327. eCollection 2025 Jun.

DOI:10.1097/XCE.0000000000000327
PMID:40160971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11952828/
Abstract

BACKGROUND

Atherosclerotic cardiovascular diseases (ASCVD), including coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral vascular disease (PVD), remain the leading cause of death globally. South Asians exhibit a higher incidence of cardiovascular diseases than other ethnicities, attributed to a range of genetic, environmental, and lifestyle factors. Lipoprotein(a) [Lp(a)] with a unique apolipoprotein(a) component, has emerged as a marker of atherosclerosis and ASCVD risk, with evidence to promote arterial plaque formation and thrombogenesis.

OBJECTIVE

The aim of this study was to explore the associations between Lp(a) levels and the severity of CAD, CVD, and PVD in a group of South Asian patients.

METHODS

Following ethical approval, 60 consecutive patients who underwent coronary angiography for any indication were reviewed. There were 51 eligible participants who were evaluated for Lp(a) level, Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score, and severity of CVD and PVD. The SYNTAX-I score was calculated using two-observer consensus on coronary angiograms. Assessment of CVD was by ultrasound/Doppler, and PVD by estimating ankle-brachial index using Doppler. The multisite arterial disease score 2 (MADS2) and SYNTAX score tertiles were used to group the patients. Statistical analysis was performed using the SPSS software.

RESULTS AND DISCUSSION

In this group, we identified a statistically significant difference with higher Lp(a) levels being associated with more severe coronary disease (SYNTAX tertile 2,3). Despite a numerical trend, statistical significance was not confirmed for Lp(a) levels in relation to MADS2-CVD or MADS2-PVD scores. A larger study may be required to assess these aspects.

摘要

背景

动脉粥样硬化性心血管疾病(ASCVD),包括冠状动脉疾病(CAD)、脑血管疾病(CVD)和外周血管疾病(PVD),仍然是全球主要的死亡原因。南亚人患心血管疾病的发病率高于其他种族,这归因于一系列遗传、环境和生活方式因素。具有独特载脂蛋白(a)成分的脂蛋白(a)[Lp(a)]已成为动脉粥样硬化和ASCVD风险的标志物,有证据表明其可促进动脉斑块形成和血栓形成。

目的

本研究的目的是探讨一组南亚患者中Lp(a)水平与CAD、CVD和PVD严重程度之间的关联。

方法

在获得伦理批准后,对连续60例因任何适应症接受冠状动脉造影的患者进行了回顾。有51名符合条件的参与者接受了Lp(a)水平、紫杉醇药物涂层支架与心脏外科手术协同作用(SYNTAX)评分以及CVD和PVD严重程度的评估。SYNTAX-I评分通过两位观察者对冠状动脉造影的共识计算得出。通过超声/多普勒评估CVD,通过使用多普勒估计踝臂指数评估PVD。使用多部位动脉疾病评分2(MADS2)和SYNTAX评分三分位数对患者进行分组。使用SPSS软件进行统计分析。

结果与讨论

在该组中,我们发现Lp(a)水平较高与更严重的冠状动脉疾病(SYNTAX三分位数2,3)之间存在统计学显著差异。尽管存在数值趋势,但未证实Lp(a)水平与MADS2-CVD或MADS2-PVD评分之间具有统计学意义。可能需要进行更大规模的研究来评估这些方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ba/11952828/e5f7dfe79c5a/xce-14-e00327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ba/11952828/30b9fd1ab4a0/xce-14-e00327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ba/11952828/e5f7dfe79c5a/xce-14-e00327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ba/11952828/30b9fd1ab4a0/xce-14-e00327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11ba/11952828/e5f7dfe79c5a/xce-14-e00327-g002.jpg

相似文献

1
Cross-sectional study of lipoprotein(a) and the severity of coronary artery disease, cerebrovascular disease, and peripheral vascular disease in a group of South Asian patients.一项针对一组南亚患者的脂蛋白(a)与冠状动脉疾病、脑血管疾病及外周血管疾病严重程度的横断面研究。
Cardiovasc Endocrinol Metab. 2025 Mar 27;14(2):e00327. doi: 10.1097/XCE.0000000000000327. eCollection 2025 Jun.
2
Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India.脂蛋白(a)和SYNTAX评分与印度北部冠状动脉粥样硬化严重程度的关联
Sultan Qaboos Univ Med J. 2012 Nov;12(4):465-72. doi: 10.12816/0003172. Epub 2012 Nov 20.
3
Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.脂蛋白(a)和低密度脂蛋白胆固醇升高可预测早发冠心病患者血管造影病变的严重程度和复杂性。
J Clin Lipidol. 2018 Jul-Aug;12(4):1019-1026. doi: 10.1016/j.jacl.2018.03.090. Epub 2018 Apr 3.
4
Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.脂蛋白(a)升高对冠状动脉疾病表型和严重程度的影响。
Eur J Prev Cardiol. 2024 May 11;31(7):856-865. doi: 10.1093/eurjpc/zwae007.
5
Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention.脂蛋白(a)水平与冠状动脉严重程度相关,但与接受经皮冠状动脉介入治疗的中国患者的结局无关。
Nutr Metab Cardiovasc Dis. 2020 Feb 10;30(2):265-273. doi: 10.1016/j.numecd.2019.09.020. Epub 2019 Sep 26.
6
Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.脂蛋白(a)和载脂蛋白(a)同工型大小:与冠状动脉疾病的血管造影程度和严重程度以及颈动脉斑块的关系。
Atherosclerosis. 2018 Aug;275:232-238. doi: 10.1016/j.atherosclerosis.2018.06.863. Epub 2018 Jun 18.
7
Association of brachial-ankle pulse wave velocity with atherosclerosis and presence of coronary artery disease in older patients.老年患者肱踝脉搏波速度与动脉粥样硬化及冠状动脉疾病存在情况的相关性
Clin Interv Aging. 2015 Aug 20;10:1369-75. doi: 10.2147/CIA.S89568. eCollection 2015.
8
Periodontitis in Patients Undergoing Coronary Angiography: A Cross-Sectional Study.接受冠状动脉造影患者的牙周炎:一项横断面研究。
Cureus. 2024 Dec 8;16(12):e75320. doi: 10.7759/cureus.75320. eCollection 2024 Dec.
9
Role of LipoprotEin(a) in CardiovascuLar diseases and premature acute coronary syndromes (RELACS study): Impact of Lipoprotein(a) levels on the premature coronary event and the severity of coronary artery disease.脂蛋白(a)在心血管疾病和早发急性冠状动脉综合征中的作用(RELACS研究):脂蛋白(a)水平对早发冠状动脉事件及冠状动脉疾病严重程度的影响
Nutr Metab Cardiovasc Dis. 2025 May;35(5):103843. doi: 10.1016/j.numecd.2024.103843. Epub 2024 Dec 24.
10
Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men.脂蛋白(a)是白人男性外周过早动脉粥样硬化的一个独立的、有鉴别意义的危险因素。
Arch Intern Med. 1994 Apr 11;154(7):801-6.

本文引用的文献

1
Hypersensitive MR angiography based on interlocking stratagem for diagnosis of cardiac-cerebral vascular diseases.基于连锁策略的高敏磁共振血管成像在心脏脑血管疾病诊断中的应用。
Nat Commun. 2023 Oct 2;14(1):6149. doi: 10.1038/s41467-023-41783-9.
2
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives.脂蛋白(a)作为心血管疾病的危险因素:病理生理学和治疗观点。
Int J Environ Res Public Health. 2023 Sep 6;20(18):6721. doi: 10.3390/ijerph20186721.
3
Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15-39 years in 204 countries/territories, 1990-2019: a systematic analysis of Global Burden of Disease Study 2019.
204 个国家/地区 1990 年至 2019 年 15-39 岁青少年和青年心血管疾病全球、区域和国家负担:2019 年全球疾病负担研究的系统分析。
BMC Med. 2023 Jun 26;21(1):222. doi: 10.1186/s12916-023-02925-4.
4
The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis.载脂蛋白(a)与心血管疾病风险的关系:一项孟德尔随机化分析。
Eur J Med Res. 2022 Oct 27;27(1):211. doi: 10.1186/s40001-022-00825-6.
5
Editorial: Novel methods to advance diagnostic and treatment value of medical imaging for cardiovascular disease.社论:提高医学成像对心血管疾病诊断和治疗价值的新方法。
Front Bioeng Biotechnol. 2022 Aug 31;10:987326. doi: 10.3389/fbioe.2022.987326. eCollection 2022.
6
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment.高血压作为动脉粥样硬化的危险因素:心血管风险评估。
Front Cardiovasc Med. 2022 Aug 22;9:959285. doi: 10.3389/fcvm.2022.959285. eCollection 2022.
7
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.脂蛋白(a)与动脉粥样硬化性心血管疾病及主动脉瓣狭窄:欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
8
Coronary Artery Disease in South Asian Patients: Cardiovascular Risk Factors, Pathogenesis and Treatments.南亚患者的冠状动脉疾病:心血管风险因素、发病机制和治疗方法。
Curr Probl Cardiol. 2023 Aug;48(8):101228. doi: 10.1016/j.cpcardiol.2022.101228. Epub 2022 Apr 29.
9
Diet and Lifestyle Factors and Risk of Atherosclerotic Cardiovascular Disease-A Prospective Cohort Study.饮食和生活方式因素与动脉粥样硬化性心血管疾病风险:一项前瞻性队列研究。
Nutrients. 2021 Oct 27;13(11):3822. doi: 10.3390/nu13113822.
10
Environmental risk factors and cardiovascular diseases: a comprehensive expert review.环境风险因素与心血管疾病:全面的专家综述。
Cardiovasc Res. 2022 Nov 10;118(14):2880-2902. doi: 10.1093/cvr/cvab316.